Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Javad Parvizi

Adult Reconstructive Orthopaedic Surgery Philadelphia, PA Medical Doctor

NPI 1184679136 CMS profile 98327

925 Chestnut St, 5Th Floor, Philadelphia, PA 19107

Open in the dashboard

General payments

$2,811,131

927 records reported · program years 2019–2025

Research payments

$15,469

Paid to them · 9 records reported · program years 2019–2025

Ownership & investment interest

$19,198

7 holdings reported · through program year 2025

Research they led as principal investigator

$2,760,079 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Javad Parvizi of Philadelphia, PA is reported in the CMS Open Payments database as having received $2,811,131 across 927 general payments and $15,469 in research payments paid to them. Separately, studies naming them as principal investigator received $2,760,079 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $19,198 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

16 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $910,969 198
2024 General $546,469 224
2023 General $294,038 181
2022 General $247,463 134
2021 General $171,190 89
2020 General $109,601 49
2020 Research $3,094 2
2019 General $531,401 52
2019 Research $12,375 7
2025 Ownership $3,232 1
2024 Ownership $2,661 1
2023 Ownership $2,661 1
2022 Ownership $2,661 1
2021 Ownership $2,661 1
2020 Ownership $2,661 1
2019 Ownership $2,661 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Javad Parvizi
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Javad Parvizi were reported at $910,969. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Javad Parvizi Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $531,401 $1,416 $292–$9,336 $163
2020 $109,601 $647 $141–$6,474 $114
2021 $171,190 $1,073 $211–$6,497 $132
2022 $247,463 $1,217 $236–$6,299 $149
2023 $294,038 $1,082 $246–$6,818 $160
2024 $546,469 $1,575 $323–$8,944 $164
2025 $910,969 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $1,036,968 140 payments
  2. Davol Inc. $853,142 540 payments
  3. Corentec America,Inc. $490,439 54 payments
  4. KCI USA, Inc $80,689 27 payments
  5. Ethicon Inc. $64,905 28 payments
  6. ConvaTec Inc. $52,846 17 payments
  7. Molnlycke Health Care US, LLC $40,040 11 payments
  8. Solventum Corporation $36,551 12 payments
  9. Smith+Nephew, Inc. $31,642 9 payments
  10. Cardinal Health 200, LLC $30,415 7 payments
  11. Other $93,495 82 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,553,588 218 payments
  2. Honoraria $459,592 87 payments
  3. Royalty or License $428,177 3 payments
  4. Travel and Lodging $174,740 375 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $133,654 27 payments
  6. Education $44,290 9 payments
  7. Food and Beverage $17,091 208 payments
Products named General payments · program years 2019–2025
  1. LOSPA Knee System $464,612 36 payments
  2. Bencox Hip System $464,612 36 payments
  3. PREVENA Negative Pressure Systems & Dressings $65,415 21 payments
  4. STRATAFIX $48,261 12 payments
  5. PREVENA Non-Covered $45,267 10 payments
  6. ARISTA AH FlexiTip $42,809 154 payments
  7. Avenir $42,633 12 payments
  8. Arcos $42,633 12 payments
  9. G7 $42,633 12 payments
  10. PREVENA RESTOR ARTHROFORM $36,301 12 payments
  11. Other $596,693 379 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Stryker Corporation $12,375 7 payments
  2. Zimmer Biomet Holdings, Inc. $3,094 2 payments

Records

936 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record